TLTFF - Theralase Technologies Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
972
1,734
2,343
1,919
Cost of Revenue
601
786
945
797
Gross Profit
371
948
1,397
1,122
Operating Expenses
Research Development
2,668
1,704
2,502
1,749
Selling General and Administrative
2,666
2,487
4,726
4,130
Total Operating Expenses
5,510
4,315
7,482
6,029
Operating Income or Loss
-5,139
-3,367
-6,085
-4,907
Interest Expense
9
1
0
0
Total Other Income/Expenses Net
-15
-8
-15
-30
Income Before Tax
-5,144
-3,357
-6,094
-4,921
Income Tax Expense
-
-
-
-
Income from Continuing Operations
-5,144
-3,357
-6,094
-4,921
Net Income
-5,144
-3,357
-6,094
-4,921
Net Income available to common shareholders
-5,144
-3,357
-6,094
-4,921
Reported EPS
Basic
-
-0.03
-0.05
-0.04
Diluted
-
-0.03
-0.05
-0.04
Weighted average shares outstanding
Basic
-
130,488
124,094
109,036
Diluted
-
130,488
124,094
109,036
EBITDA
-
-3,133
-5,840
-4,772